Trial intelligence / Profile preview

Tofacitinib Phase 3 Trial in Digestive System Disease (Japan)

jRCT2080221992Phase 3Completed

Start
Dec 2012
Modality
Small Molecules
01

Overview

Phase 3 trial of tofacitinib. Started Dec 2012; status: completed.

02

Drugs

Beyond the preview

Go deeper on jRCT2080221992.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on jRCT2080221992.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call